We hypothesize that hab019e2 may stimulate GITR on effector T cells resulting in high‐avidity T‐cell responses that were tumor‐specific in vivo just like we saw in the in vitro T‐cell activation experiment. The gene discussed is TNFRSF18; the disease is neoplasm.